InvestorsHub Logo
Post# of 252279
Next 10
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

Re: JohnStevenson post# 182025

Wednesday, 09/17/2014 10:13:46 PM

Wednesday, September 17, 2014 10:13:46 PM

Post# of 252279

Swedish Kancera making progress with ROR-inhibitor.

Do you have an opinion on Kancera? I heard of them before and have them on my watch list given they seem to be involved in novel projects, very obscure/off-the-radar, and tiny valuation. They also are working on HDAC6 and claim, at least in pre-clinic, that they have a more potent and more tolerable HDAC6 than Acetylon (CELG paid a good chunk for them earlier I believe).

One of the big risks I see is they only had ~31M SEK, or about $4.5M, as of 6/30/14. It would seem that they are going to need to raise money soon. Also, do you know how many shares are outstanding? I'd like to get a sense of fully-diluted market cap.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.